7), which was in accordance with the initial EP screen
Patients experiencing any disruptive vision changes such as blurry vision should take symptoms seriously, monitor their condition closely, and consult their healthcare provider promptly to rule out serious ocular issues and manage side effects responsibly
Being licensed means the MHRA has assessed these drugs as safe and effective for certain medical purposes
As of the end of May 2023, Medicilon has successfully assisted in the clinical approval of 7 GLP-1 drugs (3 approved by FDA and NMPA1 approved by FDA, NMPA, and TGA) and has multiple GLP-1 projects under development
The Cleveland Clinic recommends aggressive hydration for patients on GLP-1 agonists
About this article Cite this article Jensterle, M., Ferjan, S., Battelino, T